Pollen Allergy Clinical Trial
Official title:
Identification of Allergen-reactive Antibodies in the Blood of Pollen Allergic Patients
The project examines the hypothesis that monoclonal allergen-neutralizing antibodies can be recombinantly produced from B lymphocytes isolated from pollen allergic patients. Patient samples suitable for antibody cloning are selected based on seroprofiling for the respective allergens. The study aims at isolating lymphocytes from patients with potential allergen-neutralizing IgG in serum and to clone antibodies from antibody gene sequences obtained from B cells of those patients.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01500642 -
Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy
|
Phase 3 | |
| Completed |
NCT00263627 -
Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens
|
Phase 3 | |
| Terminated |
NCT04874714 -
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
|
Phase 3 | |
| Completed |
NCT04622917 -
Methylprednisolone Injections Treating Birch Pollen Induced Allergic Rhinitis.
|
Phase 4 |